HS-tk vector: Will treat up to 24 patients in an on-going Phase I/II trial

By WIR Staff | Aug 22, 1994 | 7:00 AM GMT

Genetic Therapy Inc. (GTII), Gaithersburg, Md.
Product: HS-tk

Read the full 80 word article

How to gain access

Continue reading with a
two-week free trial.